GPT Analysis
Empower Your Investments! Unleash the Potential with Smart Stock Analysis!
| Symbol | Company Name | Rating | Recommendation | Evaluation from GPT | Action | Time |
|---|---|---|---|---|---|---|
| SUZLON | Suzlon Energy Limited | 60 | Negative | Suzlon Energy Limited (SUZLON.NS) is a company listed on the National Stock Exchange of India. The stock has a current market price of INR 39.35 and a market capitalization of INR 536.15 billion. The stock's year change is 3.95%, with a year high of INR 50.60 and a year low of INR 7.90. The stock has shown an upward trend in the last year, with the 200-day average price of INR 33.02 and the 50-day average price of INR 42.40. The stock has a high trading volume, with an average of 54.03 million shares traded over the last three months. However, the stock has been trading below its previous close and the 10-day average volume, which may indicate a short-term downward trend. Considering the volatility and the recent performance of the stock, the sentiment is | | 2024-04-20 10:50:47 |
| SUVIDHAA | Suvidhaa Infoserve Limited | None | None | None | | None |
| SUVIDHAA | Suvidhaa Infoserve Limited | None | None | None | | None |
| SUVIDHAA | Suvidhaa Infoserve Limited | None | None | None | | None |
| SUVIDHAA | Suvidhaa Infoserve Limited | None | None | None | | None |
| SUVENPHAR | Suven Pharmaceuticals Limited | 80 | Positive | Suven Pharmaceuticals Limited (SUVENPHAR.NS) is a drug manufacturer specializing in specialty and generic drugs. The company operates in the healthcare sector and has a market capitalization of INR 132,501,078,016. Suven Pharmaceuticals has shown consistent growth with a trailing PE ratio of 32.25 and a profit margin of 31.45%. The company's revenue has been growing at a rate of 2.6% and its earnings have grown by 12.3% in the last quarter. Suven Pharmaceuticals has a strong balance sheet with a debt-to-equity ratio of 4.05 and a cash per share of INR 19.14. The stock has a 52-week high of INR 534.55 and a 52-week low of INR 390.5. Based on these factors, Suven Pharmaceuticals appears to be a promising investment option in the healthcare sector. | | 2023-08-18 10:29:42 |
| SUVENPHAR | Suven Pharmaceuticals Limited | None | None | None | | None |
| SUVENPHAR | Suven Pharmaceuticals Limited | None | None | None | | None |
| SUVENPHAR | Suven Pharmaceuticals Limited | None | None | None | | None |
| SUVEN | Suven Life Sciences Limited | 60 | Positive | Suven Life Sciences Limited (SUVEN.NS) is a drug manufacturer specializing in specialty and generic drugs. The company operates in the healthcare sector and has 132 full-time employees. SUVEN.NS has a market capitalization of INR 14,621,861,888 and a beta of 1.63, indicating moderate volatility compared to the market. The stock has a forward price-to-earnings ratio of 3.47, suggesting it may be undervalued. However, it is important to note that the company has | | 2023-08-18 10:29:08 |
| SUVEN | Suven Life Sciences Limited | None | None | None | | None |
| SUVEN | Suven Life Sciences Limited | None | None | None | | None |
| SUVEN | Suven Life Sciences Limited | None | None | None | | None |
| SUULD | Suumaya Industries Limited | None | None | None | | None |
| SUULD | Suumaya Industries Limited | None | None | None | | None |
| SUULD | Suumaya Industries Limited | None | None | None | | None |
| SUULD | Suumaya Industries Limited | None | None | None | | None |
| SUTLEJTEX | Sutlej Textiles and Industries Limited | None | None | None | | None |
| SUTLEJTEX | Sutlej Textiles and Industries Limited | None | None | None | | None |
| SUTLEJTEX | Sutlej Textiles and Industries Limited | None | None | None | | None |